T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEPN
2226
Septerna Inc
SEPN
$1.85B
| $710K | ﹤0.01% |
25,443
-1,981
| -7% | -$47.3K |
|
2227
Douglas Dynamics
PLOW
$912M
| $707K | ﹤0.01% |
21,652
+951
| +5% | +$30.1K |
|
2228
Global Industrial
GIC
$1.61B
| $706K | ﹤0.01% |
24,146
+1,038
| +4% | +$31.6K |
|
2229
IDT Corp
IDT
$1.73B
| $705K | ﹤0.01% |
13,765
+628
| +5% | +$31.5K |
|
|
AVNS
2230
DELISTED
Avanos Medical
AVNS
| $703K | ﹤0.01% |
62,531
+11,966
| +24% | +$137K |
|
2231
Digital Turbine
APPS
$1.36B
| $702K | ﹤0.01% |
140,271
+3,372
| +2% | +$19.1K |
|
|
DFTX
2232
Definium Therapeutics
DFTX
$5.16B
| $700K | ﹤0.01% |
52,230
+11,025
| +27% | +$136K |
|
2233
Alight
ALIT
$261M
| $699K | ﹤0.01% |
17,905
-218
| -1% | -$10.9K |
|
|
ESPR
2234
DELISTED
Esperion Therapeutics
ESPR
| $698K | ﹤0.01% |
188,639
+35,749
| +23% | +$116K |
|
2235
Jack in the Box
JACK
$263M
| $698K | ﹤0.01% |
36,828
+13,841
| +60% | +$250K |
|
2236
Winmark
WINA
$1.08B
| $697K | ﹤0.01% |
1,719
+101
| +6% | +$43.2K |
|
2237
Aehr Test Systems
AEHR
$3.22B
| $695K | ﹤0.01% |
34,384
-10,862
| -24% | -$263K |
|
2238
Fox Factory Holding Corp
FOXF
$788M
| $695K | ﹤0.01% |
40,565
-4,043
| -9% | -$77.1K |
|
2239
Scholastic
SCHL
$618M
| $695K | ﹤0.01% |
23,431
| – | – |
|
2240
Tactile Systems Technology
TCMD
$517M
| $695K | ﹤0.01% |
23,957
+1,215
| +5% | +$27K |
|
2241
Cable One
CABO
$71.3M
| $691K | ﹤0.01% |
6,123
+1,738
| +40% | +$237K |
|
2242
Dole
DOLE
$1.23B
| $690K | ﹤0.01% |
45,981
+6,348
| +16% | +$88.4K |
|
2243
Under Armour Class C
UA
$1.82B
| $688K | ﹤0.01% |
143,271
+17,467
| +14% | +$77.7K |
|
2244
Angi Inc
ANGI
$225M
| $687K | ﹤0.01% |
53,072
+10,702
| +25% | +$138K |
|
2245
iShares Russell 1000 Value ETF
IWD
$81.6B
| $687K | ﹤0.01% |
3,266
-2,858
| -47% | -$590K |
|
|
TBCH
2246
Turtle Beach Corp
TBCH
$227M
| $686K | ﹤0.01% |
48,885
+357
| +0.7% | +$5.31K |
|
2247
Mobileye
MBLY
$6.62B
| $685K | ﹤0.01% |
65,548
+13,300
| +25% | +$166K |
|
2248
Northrim BanCorp
NRIM
$545M
| $683K | ﹤0.01% |
25,662
+4,586
| +22% | +$109K |
|
|
FBRT
2249
Franklin BSP Realty Trust
FBRT
$557M
| $681K | ﹤0.01% |
67,809
+5,992
| +10% | +$62.6K |
|
|
TE
2250
T1 Energy
TE
$1.05B
| $678K | ﹤0.01% |
101,428
+42,790
| +73% | +$189K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.